INTEGRATED FILING — NBFC



General information about company

Scrip code 532737
NSE Symbol EMKAY
MSEI Symbol NOTLISTED
ISIN INE296H01011
Name of company Emkay Global Financial Services Limited
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2025
Date of end of financial year 31-03-2026
Date of board meeting when results were approved 27-01-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 14-01-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Third quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Unaudited
Segment Reporting Single segment
Description of single segment Advisory and Transactional Services
Start date and time of board meeting 27-01-2026   12:00:00
End date and time of board meeting 27-01-2026   13:15:00
Whether cash flow statement is applicable on company
Type of cash flow statement
Declaration of unmodified opinion or statement on impact of audit qualification Not applicable
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? Yes
No. of times funds raised during the quarter 1
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
There were no default on loans and Debt Securities.


Financial Results — NBFC

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-10-2025 01-04-2025
B Date of end of reporting period 31-12-2025 31-12-2025
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
1 Income
Revenue from operations
(i) Interest Income 740.97 1,585.89
(ii) Dividend Income 0.00 0.00
(iii) Rental Income 0.00 0.00
(iv) Fees and commission Income 7,105.17 18,779.22
(v) Net gain on fair value changes 42.18 244.32
(vi) Net gain on derecognition of financial instruments under amortised cost category 0.00 0.00
(vii) Sale of products (including Excise Duty) 0.00 0.00
(viii) Sale of services 0.00 0.00
(ix) Other revenue from operations
1 Other Operating Income 59.64 178.11
2 Reversal of Impairment Provision on Financial Instruments 0.29 0.00
Total other revenue from operations 59.93 178.11
Total Revenue From Operations 7,948.25 20,787.54
Other income 466.25 1,370.11
Total income 8,414.50 22,157.65
2 Expenses
Cost of materials consumed 0.00 0.00
Purchases of stock-in-trade 0.00 0.00
Changes in inventories of finished goods, work-in-progress and stock-in-trade 0.00 0.00
Employee benefit expense 4,447.22 11,868.49
Finance costs 486.71 1,204.87
Depreciation, depletion and amortisation expense 310.98 850.71
Fees and commission expense 566.85 1,742.33
Net loss on fair value changes 0.00 0.00
Net loss on derecognition of financial instruments under amortised cost category 0.00 0.00
Impairment on financial instruments 0.00 5.73
(f) Other expenses
1 Other expenses 2,168.88 6,072.01
Total other expenses 2,168.88 6,072.01
Total expenses 7,980.64 21,744.14
3 Total profit before exceptional items and tax 433.86 413.51
4 Exceptional items 0.00 0.00
5 Total profit before tax 433.86 413.51
7 Tax expense
8 Current tax 62.67 62.67
9 Deferred tax 58.11 (27.48)
10 Total tax expenses 120.78 35.19
11 Net Profit Loss for the period from continuing operations 313.08 378.32
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
17 Net profit (loss) from discontinued operation after tax 0.00 0.00
14 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
15 Total profit (loss) for period 313.08 378.32
16 Other comprehensive income net of taxes 27.56 12.52
17 Total Comprehensive Income for the period 340.64 390.84
18 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
19 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
20 Details of equity share capital
Paid-up equity share capital 2,591.08 2,591.08
Face value of equity share capital 10 10
21 Reserves excluding revaluation reserve
22 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings per share from continuing operations 1.23 1.48
Diluted earnings per share from continuing operations 1.16 1.4
ii Earnings per equity share for discontinued operations
Basic earnings per share from discontinued operations 0 0
Diluted earnings per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings per share 1.23 1.48
Diluted earnings per share 1.16 1.4
23 Debt equity ratio 0.3900 0.3900
24 Debt service coverage ratio 1.7500 1.0400
25 Interest service coverage ratio 1.7500 1.0400
26 Disclosure of notes on financial results


Remarks

23 Debt equity ratio
24 Debt service coverage ratio
25 Interest service coverage ratio




Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-10-2025 01-04-2025
B Date of end of reporting period 31-12-2025 31-12-2025
Whether results are audited or unaudited Unaudited Unaudited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets
Net Segment Asset
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities
Net Segment Liabilities
Disclosure of notes on segments


Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-10-2025 01-04-2025
B Date of end of reporting period 31-12-2025 31-12-2025
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Re-measurement gains/losses on defined benefit plans 3299000 1795000
Total Amount of items that will not be reclassified to profit and loss 3299000 1795000
2 Income tax relating to items that will not be reclassified to profit or loss 5.43 5.43
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss 0.00 0.00
5 Total Other comprehensive income 27.56 12.52




Statement on Deviation or Variation for proceeds of Public Issue, Rights Issue, Preferential Issue, Qualified Institutions Placement Etc. (1)

Amount in (Lakhs)

Mode of Fund Raising Preferential Issues
Description of mode of fund raising (Applicable in case of others is selected)
Date of Raising Funds 24-10-2025
Amount Raised 22,752.50
Report filed for Quarter ended 31-12-2025
Monitoring Agency Applicable
Monitoring Agency Name, if applicable CARE Ratings Limited
Is there a Deviation / Variation in use of funds raised No
If yes, whether the same is pursuant to change in terms of a contract or objects, which was approved by the shareholders
If Yes, Date of shareholder Approval
Explanation for the Deviation / Variation NIL
Comments of the Audit Committee after review NIL
Comments of the auditors, if any NIL
Sr. Original Object Modified Object, if any Original Allocation Modified allocation, if any Funds Utilised Amount of Deviation/Variation for the quarter according to applicable object Remarks if any
1 Working Capital and General Corporate Purpose No 100.00 0.00 100.00 0.00 During the quarter ended December 31, 2025, the Management Committee in its meeting on October 24, 2025 allotted 95,00,000 convertible warrants on a preferential basis of Rs. 227,52,50,000/- to Promoter and Non-Promoter as approved in Extra-Ordinary General Meeting held on October 17, 2025. As on reporting date, the Company has received Rs. 56,88,12,500/- (25% of subscription amount of the issue price) on October 24, 2025 and Rs. 4,99,89,637.50/- received on conversion of 2,78,300 warrants into 2,78,300 equity shares by one of the Promoters.


Signatory Details

Name of signatory Saket Agrawal
Designation of person Chief Financial Officer
Place Mumbai
Date 27-01-2026